Iron parameters in patients with partial lipodystrophy and impact of exogenous leptin therapy

被引：0
|
作者：
Akinci, Efe Y. [1 ,2 ]
Boutros, Sabine [1 ,2 ]
Ryan, Benjamin J. [3 ]
Sargin, Pinar [1 ,2 ]
Akinci, Baris [1 ,2 ]
Neidert, Adam H. [1 ,2 ]
Hench, Rita [1 ,2 ]
Horowitz, Jeffrey F. [3 ]
Oral, Elif A. [1 ,2 ]
机构：
[1] Univ Michigan, Brehm Ctr Diabet Res, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Kinesiol, Substrate Metab Lab, Ann Arbor, MI 48109 USA
来源：
BMJ OPEN DIABETES RESEARCH & CARE | 2021年 / 9卷 / 01期
基金：
美国国家卫生研究院;
关键词：
SERUM FERRITIN;
D O I：
10.1136/bmjdrc-2021-002385
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy
    Moran, SA
    Patten, N
    Young, JR
    Cochran, E
    Sebring, N
    Reynolds, J
    Premkumar, A
    Depaoli, AM
    Skarulis, MC
    Oral, EA
    Gorden, P
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (04): : 513 - 519
  • [22] Effect of subcutaneous leptin replacement therapy on bone metabolism in patients with generalized lipodystrophy
    Simha, V
    Zerwekh, JE
    Sakhaee, K
    Garg, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11): : 4942 - 4945
  • [23] Metreleptin in Patients with Partial Lipodystrophy
    Ajluni, Nevin
    Dar, Moahad
    Xu, John
    Isupov, Taisia
    Neidert, Adam
    Oral, Elif A.
    DIABETES, 2015, 64 : A527 - A527
  • [24] Patient Quality of Life and Benefits of Leptin Replacement Therapy (LRT) in Generalized and Partial Lipodystrophy (GL, PL)
    Ali, Omer A.
    Cook, Keziah
    Shampanier, Kristina S.
    Tuttle, Edward
    Gerrits, Charles
    Brown, Rebecca
    DIABETES, 2018, 67
  • [25] Effect of leptin replacement therapy (LRT) on survival and disease progression in generalised and partial lipodystrophy (GL, PL)
    Cook, K.
    Ali, O.
    Gupta, D.
    Holmqvist, D.
    Lee, D.
    Ng, C.
    Bradt, P.
    Brown, R.
    DIABETOLOGIA, 2018, 61 : S86 - S86
  • [26] A patient with familial partial lipodystrophy with a PPAR-γ mutation and the long-term effect of leptin therapy
    Park, Jean Y.
    Cochran, Elaine K.
    Poitou, Christine
    Clement, Karine
    Magre, Jocelyne
    Gorden, Phillip
    DIABETES, 2007, 56 : A581 - A581
  • [27] Effect of Leptin Replacement Therapy (LRT) on Survival and Disease Progression in Generalized and Partial Lipodystrophy (GL, PL)
    Ali, Omer A.
    Cook, Keziah
    Gupta, Deepshekhar
    Holmqvist, Dan
    Lee, Don
    Ng, Courtney K.
    Bradt, Pamela
    Brown, Rebecca
    DIABETES, 2018, 67
  • [28] Patients with lamin mutations in familial partial lipodystrophy have low free but high bound leptin
    Brabant, G
    Schmidt, M
    Ockenga, J
    Horn, R
    von zur Mühlen, A
    Schäfer, J
    Schmidt, H
    DIABETOLOGIA, 2000, 43 : A174 - A174
  • [29] Efficacy of leptin therapy in the different forms of human lipodystrophy
    A. Y. Chong
    B. C. Lupsa
    E. K. Cochran
    P. Gorden
    Diabetologia, 2010, 53 : 27 - 35
  • [30] RATIONALE FOR LEPTIN-REPLACEMENT THERAPY FOR SEVERE LIPODYSTROPHY
    Oral, Elif A.
    Chan, Jean L.
    ENDOCRINE PRACTICE, 2010, 16 (02) : 324 - 333
12345